SCHEMBL6307965

SCHEMBL6307965

Cc1nc2ccc(C(=O)O)cc2n1Cc1ccc(-c2ccco2)cc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 2/20 0.47
▸ MAPT P10636 2/20 0.43
▸ POLB P06746 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ NSD2 O96028 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ THRB P10828 1/20 0.43
▸ PABPC1 P11940 1/20 0.43
▸ TNNI3 P19429 1/20 0.43
▸ TNNT2 P45379 1/20 0.43
▸ TNNC1 P63316 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ KEAP1 Q14145 1/20 0.42
▸ HDAC3 O15379 1/20 0.40
▸ HDAC4 P56524 1/20 0.40
▸ HDAC1 Q13547 1/20 0.40
▸ HDAC7 Q8WUI4 1/20 0.40
▸ HDAC2 Q92769 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6389924 0.89 PPARG (0.46) PPARGMAPTPOLBMEN1ALDH1A1
SCHEMBL6307363 0.86 PPARG (0.51) PPARGMAPTALDH1A1HDAC3HDAC4
SCHEMBL6301598 0.86 PPARG (0.53) PPARGMAPTPOLBALDH1A1HDAC3
SCHEMBL7651458 0.85 PPARG (0.56) PPARGMAPTALDH1A1HDAC3HDAC4
SCHEMBL6301204 0.84 PPARG (0.55) PPARGMAPTPOLBALDH1A1HDAC3
SCHEMBL6303404 0.84 PPARG (0.51) PPARGMAPTPOLBMEN1ALDH1A1
SCHEMBL7655132 0.83 PPARG (0.53) PPARGMAPTALDH1A1HDAC3HDAC4
SCHEMBL6308877 0.83 PPARG (0.52) PPARGMAPTPOLBALDH1A1HDAC3
SCHEMBL6308880 0.83 PPARG (0.52) PPARGMAPTPOLBALDH1A1HDAC3
SCHEMBL6503942 0.83 ALDH1A1 (0.39) PPARGMAPTPOLBMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6869950-B1 Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-03-22 — — US disclosed
US-6420409-B1 GLUCOSE TOLERANCE, DIABETES,INSULIN RESISTANCE, POLYCYSTIC OVARY SYNDROME, HYPERLIPIDEMIA, ATHEROSCLEROSIS, CARDIOVASCULAR DISORDERS, HYPERGLYCEMIA, HYPERTENSION, STENOCARDIA, PULMONARY HYPERTENSION, CONGESTIVE HEART FAILURE, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-07-16 — — US disclosed
EP-1142880-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-10-10 — — EP disclosed
EP-1020452-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-19 — — EP disclosed
Send feedback